High serum YKL-40 level positively correlates with coronary artery disease

被引:2
|
作者
Jin, Yan [1 ]
Cao, Jia-Ning [1 ]
Wang, Chun-Xia [1 ]
Feng, Qiu-Ting [1 ]
Ye, Xin-He [1 ]
Xu, Xin [1 ]
Yang, Cheng-Jian [1 ]
机构
[1] Nanjing Med Univ, WuXi Hosp 2, Dept Cardiol, 68 Zhongshan Rd, Wuxi 214002, Peoples R China
关键词
CAD; coronary artery disease; diagnosis; Gensini score; predictive value; ROC curve; sensitivity; serum; specificity; YKL-40; HEART-DISEASE; INFLAMMATORY BIOMARKER; PROMOTER REGION; PLASMA YKL-40; ATHEROSCLEROSIS; CHI3L1; MARKER; GENE; EXPRESSION; PREDICTION;
D O I
10.2217/bmm-2016-024
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Aim: We investigated the predictive value of chitinase-like protein YKL-40 in coronary artery disease (CAD). Patients: Serum YKL-40 levels in 116 CAD patients and 82 healthy controls were analyzed. Severity of CAD was evaluated using Gensini scores. Spearman's correlation was used to evaluate the correlation between Gensini scores and YKL-40 levels. The predictive value of YKL-40 was determined by receivers operating characteristic curve analysis. Results: Serum YKL-40 levels were significantly elevated in CAD group as compared with control group. A positive correlation was found between the serum YKL-40 level and Gensini score. The optimum cut-off value of YKL-40 concentration was 127.7 ng/ ml for distinguishing CAD patients from healthy controls with a 75.9% sensitivity and 57.3% specificity. Conclusion: A positive correlation exists between YKL-40 levels and CAD, and YKL-40 might be a useful adjunct in the diagnosis of CAD.
引用
收藏
页码:133 / 139
页数:7
相关论文
共 50 条
  • [31] YKL-40 Protein Correlates with the Phenotype of Asthma
    Krzysztof Specjalski
    Marta Chełmińska
    Ewa Jassem
    Lung, 2015, 193 : 189 - 194
  • [32] YKL-40 correlates with eosinophilia in asthmatic population
    Specjalski, K.
    Lewandowska, K.
    Jassem, E.
    ALLERGY, 2011, 66 : 465 - 465
  • [33] Could YKL-40 be used as a new marker for coronary artery ectasia?
    Kim, Byung Jin
    ANADOLU KARDIYOLOJI DERGISI-THE ANATOLIAN JOURNAL OF CARDIOLOGY, 2013, 13 (05): : 471 - 472
  • [34] CLINICAL SIGNIFICANCE OF SERUM YKL-40 IN BEHCET'S DISEASE
    Kim, D. Y.
    Seo, J.
    Ahn, Y.
    Zheng, Z.
    Bang, D.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2016, 34 (06) : S164 - S164
  • [35] YKL-40 is associated with long-term mortality in patients with stable coronary artery disease
    Harutyunyan, M.
    Winkel, P.
    Hilden, J.
    Goetze, J. P.
    Johansen, J. S.
    Hansen, J. F.
    Jensen, G. B.
    Kjoeller, E.
    Kolmos, H. J.
    Kastrup, J.
    EUROPEAN HEART JOURNAL, 2012, 33 : 781 - 781
  • [36] Elevated serum YKL-40 levels in patients with Kawasaki disease
    Kim, K. Y.
    Ahn, Y.
    Kim, D. Y.
    Kim, Ho-Seong
    Kim, D. S.
    BIOMARKERS, 2017, 22 (3-4) : 326 - 330
  • [37] Serum YKL-40 isassociated with bone disease in multiple myeloma
    Mylin, A. K.
    Abildgaard, N.
    Johansen, J. S.
    Andersen, N. F.
    Gimsing, P.
    Knudsen, L. M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 130 - 130
  • [38] The association of YKL-40 genetic polymorphisms with coronary artery disease in Taiwan population and diabetes subgroup
    Ting, Ke Hsin
    Yang, Shun Fa
    Wang, Po Hui
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 120 : S86 - S86
  • [39] YKL-40 Protein Correlates with the Phenotype of Asthma
    Specjalski, Krzysztof
    Chelminska, Marta
    Jassem, Ewa
    LUNG, 2015, 193 (02) : 189 - 194
  • [40] Association between serum YKL-40 level and dysglycemia in cystic fibrosis
    Bouvet, Guillaume F.
    Maignan, Maxime
    Arslanian, Elizabeth
    Coriati, Adele
    Rabasa-Lhoret, Remi
    Berthiaume, Yves
    CYTOKINE, 2015, 71 (02) : 296 - 301